Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design

Annelienke M. van Hulst; Martha A. Grootenhuis; Erica L.T. van den Akker; Marry M. van den Heuvel-Eibrink

doi:10.1016/j.ejca.2023.112980

Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design

Annelienke M. van Hulst
, Martha A. Grootenhuis
, Erica L.T. van den Akker
, Marry M. van den Heuvel-Eibrink

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

Originele taal-2	Engels
Artikelnummer	112980
Tijdschrift	European Journal of Cancer
Volume	191
DOI's	https://doi.org/10.1016/j.ejca.2023.112980
Status	Gepubliceerd - sep 2023

Toegang tot document

10.1016/j.ejca.2023.112980

Citeer dit

van Hulst, A. M., Grootenhuis, M. A., van den Akker, E. L. T., & van den Heuvel-Eibrink, M. M. (2023). Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design. European Journal of Cancer, 191, Artikel 112980. https://doi.org/10.1016/j.ejca.2023.112980

van Hulst, Annelienke M. ; Grootenhuis, Martha A. ; van den Akker, Erica L.T. et al. / Response to letter entitled : Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design. In: European Journal of Cancer. 2023 ; Vol. 191.

@article{1d7d43d80e6645738bb07e1c2252e478,

title = "Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design",

author = "\{van Hulst\}, \{Annelienke M.\} and Grootenhuis, \{Martha A.\} and \{van den Akker\}, \{Erica L.T.\} and \{van den Heuvel-Eibrink\}, \{Marry M.\}",

year = "2023",

month = sep,

doi = "10.1016/j.ejca.2023.112980",

language = "English",

volume = "191",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

van Hulst, AM, Grootenhuis, MA, van den Akker, ELT & van den Heuvel-Eibrink, MM 2023, 'Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design', European Journal of Cancer, vol. 191, 112980. https://doi.org/10.1016/j.ejca.2023.112980

Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design. / van Hulst, Annelienke M.; Grootenhuis, Martha A.; van den Akker, Erica L.T. et al.
In: European Journal of Cancer, Vol. 191, 112980, 09.2023.

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

TY - JOUR

T1 - Response to letter entitled

T2 - Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design

AU - van Hulst, Annelienke M.

AU - Grootenhuis, Martha A.

AU - van den Akker, Erica L.T.

AU - van den Heuvel-Eibrink, Marry M.

PY - 2023/9

Y1 - 2023/9

UR - https://www.scopus.com/pages/publications/85168808132

U2 - 10.1016/j.ejca.2023.112980

DO - 10.1016/j.ejca.2023.112980

M3 - Letter

C2 - 37574396

AN - SCOPUS:85168808132

SN - 0959-8049

VL - 191

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 112980

ER -

van Hulst AM, Grootenhuis MA, van den Akker ELT, van den Heuvel-Eibrink MM. Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design. European Journal of Cancer. 2023 sep;191:112980. doi: 10.1016/j.ejca.2023.112980